Treatment and research lines for the patient with COVID-19. What do we have and where are we going?
Int. braz. j. urol
;
46(supl.1): 125-132, July 2020. tab
Article
in English
| LILACS
| ID: biblio-1134278
ABSTRACT
ABSTRACT Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents the most significant global public health crisis of this generation. From the beginning of the pandemic, several publications and on-line resources about different treatment lines have been done, and development effort in response to the COVID-19 pandemic to investigate potential therapies is unprecedented. Unfortunately, until now, there is not enough evidence to recommend any specific anti-COVID19 treatment. Randomized clinical trials and high-quality evidence, even in the middle of a pandemic, are needed. We provide a review of the latest published literature on the therapeutic strategies and current investigational lines for SARS-CoV-2.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Pneumonia, Viral
/
Coronavirus Infections
/
Biomedical Research
Type of study:
Controlled clinical trial
Limits:
Humans
Language:
English
Journal:
Int. braz. j. urol
Journal subject:
Urology
Year:
2020
Type:
Article
Affiliation country:
Spain
Institution/Affiliation country:
IIS-Fundación Jiménez Díaz - ISCIII-CIBERES/ES
Similar
MEDLINE
...
LILACS
LIS